Explore more publications!
My Africa News Online
Got News to Share?

My Africa News Online: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on My Africa News Online.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 5, 2025

NBCI Announce The 25 Most Effective Christian Biblical Preachers of 2025-2026 in the Black Preaching Tradition
December 5, 2025

NBCI Announce The 25 Most Effective Christian Biblical Preachers of 2025-2026 in the Black Preaching Tradition

Indeterminate EIN Presswire
Image Diplomacy becomes Bloomberg Media's exclusive commercial partner in EastAfrica & Mauritius
December 5, 2025

Image Diplomacy becomes Bloomberg Media's exclusive commercial partner in EastAfrica & Mauritius

Indeterminate EIN Presswire
Good Dad Act Committee Highlights Kentucky & Florida Paternity Laws & Reaffirms - 2024 Legislative Proposal to Kentucky
December 5, 2025

Good Dad Act Committee Highlights Kentucky & Florida Paternity Laws & Reaffirms - 2024 Legislative Proposal to Kentucky

Indeterminate EIN Presswire
Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification
December 5, 2025

Clearmind Medicine Announces Receipt of Nasdaq Minimum Bid Price Notification

Indeterminate GlobeNewswire
Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares
December 5, 2025

Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares

Indeterminate GlobeNewswire
Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 5, 2025

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 5, 2025

Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering

Indeterminate GlobeNewswire
Emerita Receives Official Court Resolution in Aznalcóllar Trial
December 5, 2025

Emerita Receives Official Court Resolution in Aznalcóllar Trial

Indeterminate GlobeNewswire
Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures
December 5, 2025

Rapport Therapeutics Announces New Data and Post Hoc Analysis Demonstrating the Magnitude and Consistency of RAP-219’s Clinical Response in Patients with Focal Onset Seizures

Indeterminate GlobeNewswire
XT Exchange Rolls Out Soccer Prediction Cycle 2 With a $3,000,000 Reward Pool and 20% XScore Rebate
December 5, 2025

XT Exchange Rolls Out Soccer Prediction Cycle 2 With a $3,000,000 Reward Pool and 20% XScore Rebate

Indeterminate GlobeNewswire
GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models
December 5, 2025

GeneLife Expands GeneAI Forecast With New Cancer Risk Prediction Models

Indeterminate GlobeNewswire
Mirasol Announces Change in Chief Financial Officer
December 5, 2025

Mirasol Announces Change in Chief Financial Officer

Indeterminate GlobeNewswire
Koryx Copper Provides Update on Zambia Projects with Definition of Drill Targets at Luanshya West and Completion of Regional Surface Geochemistry at Mpongwe
December 5, 2025

Koryx Copper Provides Update on Zambia Projects with Definition of Drill Targets at Luanshya West and Completion of Regional Surface Geochemistry at Mpongwe

Indeterminate GlobeNewswire
Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 5, 2025

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
MEXC Reports 1,329% Average Peak Return Across Top New Tokens in November
December 5, 2025

MEXC Reports 1,329% Average Peak Return Across Top New Tokens in November

Indeterminate GlobeNewswire
Sapu Nano Announce Deciparticle™ Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine
December 5, 2025

Sapu Nano Announce Deciparticle™ Led Biomarker Framework Identifying Tumors Most Likely to Respond to IV Sapu003, an Intravenous Everolimus Nanomedicine

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions